Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Eotaxin expression after segmental allergen challenge in subjects with atopic asthma.
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy in vivo.
Tolazamide
HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives.
Medical Management of the Severe Traumatic Brain Injury Patient.
See All 14 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Medical Management of the Severe Traumatic Brain Injury Patient.
Marehbian J, Muehlschlegel S, Edlow BL, Hinson HE, Hwang DY. Medical Management of the Severe Traumatic Brain Injury Patient. Neurocrit Care. 2017 Dec; 27(3):430-446.
View in:
PubMed
subject areas
Brain Injuries, Traumatic
Critical Care
Emergency Medical Services
Humans
Practice Guidelines as Topic
authors with profiles
Susanne Muehlschlegel MD, MPH